Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jan 2022 for Kiora Pharmaceuticals INC, €312. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen From: trading record in brief
This profile gathers the share dealings of Stephen From in Kiora Pharmaceuticals Inc, where the filings describe the role as chief executive. The record holds 9 filings, for trades running from 4 May 2021 to 5 January 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 6 January 2022: a share grant of €312, in Kiora Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen From
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
326 shares@ US$1.0824.9% of flowCommon StockSEC:0001104659-22-001942:0
273 shares@ US$1.3050.2% of flowCommon StockSEC:0001104659-21-147638:0
250 shares@ US$1.984.0% of flowCommon StockSEC:0001104659-21-133655:0
249 shares@ US$2.014.1% of flowCommon StockSEC:0001104659-21-123265:0
253 shares@ US$1.813.6% of flowCommon StockSEC:0001104659-21-112942:0
261 shares@ US$2.405.0% of flowCommon StockSEC:0001104659-21-100200:0
877 shares@ US$3.7025.8% of flowCommon StockSEC:0001104659-21-089442:0
878 shares@ US$4.1928.6% of flowCommon StockSEC:0001104659-21-077766:0
889 shares@ US$4.1328.8% of flowCommon StockSEC:0001104659-21-061950:0
9 of 9 declarations
